UBER vs VIR · P/E 18, rev $52.02B vs rev $74.2M
Uber Technologies Inc (UBER) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Latest reported VIR revenue for 2024-12-31 was $74.2M. Net income was -$522.0M. Revenue was down 13.9% from 2023-12-31 to 2024-12-31. VIR currently screens at market cap $1.45B.
UBER currently screens at market cap $144.34B and trailing P/E 17.6. VIR currently screens at market cap $1.45B.
Not investment advice. Open the UBER and VIR stock pages for the full models.
Not investment advice.